StonvexLoading…
StonvexStonvexStonvexCore line items from MRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $16.52B | $16.29B | $65.01B | $48.61B | $31.34B |
Operating Income | Not available | $-3.53B | $21.07B | $17.65B | $10.90B |
Net Income | Not available | $-4.24B | $18.25B | $15.29B | $9.51B |
EPS (Diluted) | $2.13 | $-1.72 | $7.28 | $6.08 | $3.77 |
Total Assets | Not available | $128.69B | $136.87B | $129.55B | $117.52B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $5.33B | $14.56B | $18.17B | $8.01B |
Free Cash Flow OCF − CapEx | Not available | $2.93B | $12.36B | $10.54B | $3.70B |
Shares Outstanding | Not available | 2.47B | 2.51B | 2.51B | 2.52B |